FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula I wherein R means C1-6alkyl, C1-6halogenalkyl, hydroxy-C1-6alkyl, hydroxygroup or halogen; m, n is equal to 0 or 1; Z1 means CH or NH; Z2 means CH or N; Z3 means CR1, N or NR2; R1 means H, C1-6alkyl, C3-7cycloalkyl, cyanogroup, cyano-C1-6alkyl or halogen; R2 means H or C1-6alkyl; X means CH, CR' or N; X' means CH, CR' or N; r is equal to 1; Y means CH or CR'; R' means R'a or R'b; R'a means a halogen or cyanogroup; R'b means C1-6alkyl, heterocycloalkyl specified in piperazinyl, morpholinyl, piperidinyl, thiomorpholinyl, azetidinyl, pyrrolidinyl, OR", SR", S(=O)2R" or NR"R", optionally substituted by one or more R'c; R'c means a hydroxygroup, oxogroup, cyanogroup, C1-6alkyl, pyridinyl, carboxy-C1-6alkyl, aminocarbonyl-C1-6alkylaminogroup, C1-6alkylaminogroup, C1-6dialkylaminogroup or C1-6alkoxygroup; R" means H, C1-6alkyl, hydroxy-C1-6alkyl, piperidinyl, C3-7cycloalkyl or pyridinyl; Q means S(=O)2Q1, C(=O)Q2, C(=O)OQ3 or Q4; Q1 means C1-6alkyl, C3-7cycloalkyl-C1-6alkyl, C1-6alkylaminogroup or C1-6dialkylaminogroup optionally substituted by one or more Q1'; each Q1' independently means C1-6alkyl or cyanogroup; Q2 means C1-6alkyl optionally substituted by one or more Q2'; each Q2' independently means a cyanogroup; Q3 means C1-6alkyl; Q4 means C1-6alkyl, oxetanyl optionally substituted by one or more Q4'; each Q4' independently means a halogen, cyanogroup, cyano-C1-6alkyl; p is equal to 0, 1 or 2; q is equal to 1 or 2; each means a single bond or a double bond; provided one of Z1 and Z2, and Z3 and Z3 bonds are double and single.
EFFECT: compounds of formula I as JAK inhibitors.
23 cl, 2 tbl, 121 ex
Title | Year | Author | Number |
---|---|---|---|
PYRROL[2,3-B]PYRAZINES AS SYK INHIBITORS | 2013 |
|
RU2656853C2 |
NOVEL 2,4-DIAMINOTHIAZOL-5-ONE DERIVATIVES | 2005 |
|
RU2395501C2 |
NOVEL DERIVATIVES OF 2,6-DIAMINOPYRIDIN-3-ONE | 2005 |
|
RU2385866C2 |
DERIVATIVES OF 4-AMINO-6-PHENYLPYRROLO[2,3]PYRIMIDINE POSSESSING INHIBITORY EFFECT ON TYROSINE KINASE ACTIVITY, THEIR USING AND METHODS FOR THEIR PREPARING (VARIANTS) | 2002 |
|
RU2318826C2 |
BICYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND INTERMEDIATE COMPOUNDS | 1998 |
|
RU2219178C2 |
PYRAZOLEPYRIMIDINES | 2005 |
|
RU2412186C2 |
4-AMINO-5-PHENYL-7-CYCLOBUTYLPYRROLO[2,3-D]PYRIMIDINE DERIVATIVES | 2002 |
|
RU2305682C2 |
PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
CERTAIN PROTEIN KINASE INHIBITORS | 2015 |
|
RU2671494C2 |
JNK INHIBITORS | 2009 |
|
RU2504545C2 |
Authors
Dates
2015-01-10—Published
2010-09-07—Filed